These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23911808)

  • 1. Treatment of central type lung cancer by combined cryotherapy: experiences of 47 patients.
    Zhikai Z; Lizhi N; Liang Z; Jianying Z; Fei Y; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Oct; 67(2):225-9. PubMed ID: 23911808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer.
    Yuanying Y; Lizhi N; Feng M; Xiaohua W; Jianying Z; Fei Y; Feng J; Lihua H; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Oct; 67(2):235-40. PubMed ID: 23948179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryosurgery for malignant endobronchial tumors: analysis of outcome.
    Asimakopoulos G; Beeson J; Evans J; Maiwand MO
    Chest; 2005 Jun; 127(6):2007-14. PubMed ID: 15947313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers.
    Li X; Zhao M; Wang J; Fan W; Li W; Pan T; Wu P
    AJR Am J Roentgenol; 2013 Dec; 201(6):1362-7. PubMed ID: 24261378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical observation on the combined treatment of 57 cases of non-small cell lung cancer using argon-helium cryosurgery and Chinese herbal medicine.
    Hu KW; Li QW; Zuo MH; Sun T; Jiang M
    Chin J Integr Med; 2007 Sep; 13(3):224-7. PubMed ID: 17898956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
    Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
    Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.
    Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Shimizu K; Imai H; Utsugi M; Iwasaki Y; Iijima H; Tsurumaki H; Yoshii A; Fueki N; Hisada T; Ishizuka T; Saito R; Mori M
    Lung Cancer; 2010 Jul; 69(1):99-104. PubMed ID: 19853960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
    Baumann P; Nyman J; Hoyer M; Wennberg B; Gagliardi G; Lax I; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JA; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
    J Clin Oncol; 2009 Jul; 27(20):3290-6. PubMed ID: 19414667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
    Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
    Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
    Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
    Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
    Hof H; Muenter M; Oetzel D; Hoess A; Debus J; Herfarth K
    Cancer; 2007 Jul; 110(1):148-55. PubMed ID: 17516437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryosurgery for lung cancer: clinical results and technical aspects.
    Maiwand MO; Asimakopoulos G
    Technol Cancer Res Treat; 2004 Apr; 3(2):143-50. PubMed ID: 15059020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination percutaneous cryotherapy and iodine-125 seed implantation for unresectable malignant thymoma: experience in 19 patients.
    Zhang Z; Wu B; Niu L; Mu F; Chen J; Li J; Zuo J; Xu K
    Cryobiology; 2013 Oct; 67(2):170-4. PubMed ID: 23846104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
    Fernando HC; De Hoyos A; Landreneau RJ; Gilbert S; Gooding WE; Buenaventura PO; Christie NA; Belani C; Luketich JD
    J Thorac Cardiovasc Surg; 2005 Mar; 129(3):639-44. PubMed ID: 15746749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
    Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1306-12. PubMed ID: 17976467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous cryotherapy for metastatic bladder cancer: experience with 23 patients.
    Liang Z; Fei Y; Lizhi N; Jianying Z; Zhikai Z; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2014 Feb; 68(1):79-83. PubMed ID: 24368268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
    Huang W; Hu J; Yang DW; Fan XT; Jin Y; Hou YY; Wang JP; Yuan YF; Tan YS; Zhu XZ; Bai CX; Wu Y; Zhu HG; Lu SH
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1160-7. PubMed ID: 23043084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention.
    Kodama H; Yamakado K; Takaki H; Kashima M; Uraki J; Nakatsuka A; Takao M; Taguchi O; Yamada T; Takeda K
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):563-9. PubMed ID: 21748451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.